Project Grant R56NS134824

Award Date 9/11/24
Completion Date 8/31/25
Dollars Obligated $546K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $566,089 to The Ohio State University to conduct research on the impacts of pneumonia on spinal cord injury recovery. The research aims to identify the mechanisms by which acute pneumonia exacerbates spinal cord injury, with a focus on understanding the role of circulatory...
This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded The Ohio State University a $119,018 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program. This grant will support research into strategies to interrogate and enhance myelin remodeling in distal tissue after spinal cord injury. The goal of the NINDS program is to fund basic and applied research exploring the brain, nervous system structure...
This $341,958 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to define the contribution of the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) and its downstream signaling to the development of chronic neuropathic pain after spinal cord injury (SCI). The key products and services to be delivered...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Drexel University a $405,625 Project Grant (R21NS131962) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The funding will support research to investigate the modular organization of respiratory control and changes in the respiratory system after cervical spinal cord injury (SCI) in freely behaving rats. The project aims to: 1) identify basic respiratory modules and...
This $391,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to develop effective therapeutic strategies for spinal cord injury (SCI) by evaluating controlled PTEN deletion and chondroitin sulfate proteoglycans (CSPGs) degradation to promote axon regeneration and functional recovery. The key objectives are to: 1) Temporally evaluate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $506,696 to the University of Washington to examine the impact of aging and sex differences on microvascular response and functional outcomes following spinal cord injury (SCI) in a rodent model. The key objectives are to: 1) Monitor the spatial and temporal development of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...
This $429,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of Schwann cell PIEZO1 in pain sensation. The key objectives are to: 1) develop and validate adeno-associated virus (AAV) vectors for selective inhibition of Schwann cell PIEZO1, and 2) determine the sensory effects of Schwann cell...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $151,559 to Rensselaer Polytechnic Institute (RPI) from August 3, 2024 to July 31, 2026. The project aims to develop innovative magnetically responsive drug delivery electrospun fibers to improve regeneration after spinal cord injury (SCI). Specifically, the research will focus...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $545,612 to The Ohio State University to conduct research aimed at reducing adipose tissue dysfunction and metabolic complications after spinal cord injury (SCI). The key objectives are to evaluate the extent to which modulating the A2D1 subunit of voltage-gated calcium channels can normalize adipose tissue function, dissect the cellular mechanisms underlying A2D1-dependent changes in adipose tissue lipolysis, and explore the role of vascular cells in adipose tissue dysfunction and inflammation after SCI. The award, effective from September 11, 2024 through August 31, 2025, is expected to provide novel insights into the molecular causes and mechanisms underlying maladaptive sensory processing and adipose tissue function following SCI, potentially facilitating the development of strategies to reduce metabolic and cardiovascular complications in this patient population.

Generated 7/1/25, 3:07 AM